The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1100
March 19, 2001
View Complete Issue         Table of Contents 2019 
Direct-to-consumer Advertisements For Glucophage XR
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Direct-to-consumer Advertisements For Glucophage XR
March 19, 2001 (Issue: 1100)
Full-page newspaper advertisements addressed to patients with type 2 diabetes are promoting the convenience of "NEW once-a-day Glucophage XR (metformin HCl extended-release tablets),"and offering a coupon for a free 30-day supply in the month of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Direct-to-consumer Advertisements For Glucophage XR
Article code: 1100b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.